Cargando…

Informational needs assessment of non‐Hodgkin lymphoma survivors and their physicians

Detalles Bibliográficos
Autores principales:	Friedman, Daphne R., Coan, April D., Smith, Sophia K., Herndon, James E., Abernethy, Amy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Subscription Services, Inc., A Wiley Company 2010
Materias:	Letters and Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160829/ https://www.ncbi.nlm.nih.gov/pubmed/20575038 http://dx.doi.org/10.1002/ajh.21725

Ejemplares similares

Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas.
por: Taylor, G. M.
Publicado: (1996)

The Need for an Early Biomarker of Cardiovascular Disease in Survivors of Hodgkin Lymphoma
por: Ness, Kirsten K.
Publicado: (2021)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
por: Biasoli, Irene, et al.
Publicado: (2023)

Rituximab induced hypoglycemia in non-Hodgkin's lymphoma
por: Hussain, Badrudeen M, et al.
Publicado: (2006)

Fertility in female survivors of Hodgkin's lymphoma
por: Biasoli, Irene, et al.
Publicado: (2012)

Cutaneous Involvement in Hodgkin Lymphoma: A Rare Case Report
por: Saavedra-Portales, Stephanie, et al.
Publicado: (2022)

Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors
por: Crespi, Catherine M., et al.
Publicado: (2009)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
por: Abeykoon, Jithma P., et al.
Publicado: (2019)

Post-treatment parenthood in Hodgkin's lymphoma survivors
por: Kiserud, C E, et al.
Publicado: (2007)

Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma
por: Mata, Elena, et al.
Publicado: (2019)

A Rare Case Report of Photosensitivity in Non-Hodgkin’S Lymphoma Treated with Lenalidomide
por: Soni, Rajesh K, et al.
Publicado: (2020)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers
por: Sud, Amit
Publicado: (2017)

Successful Management of a Rare Case of Humerus Non-Hodgkin's Lymphoma in Rapid Progress
por: Liu, Shu-Zhong, et al.
Publicado: (2018)

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
por: Posthuma, Hidde L. A., et al.
Publicado: (2021)

Incorporation of Ruxolitinib in the Management of Refractory/Relapsed Hodgkin Lymphoma: Where Do We Stand?
por: Al Sharie, Ahmed H., et al.
Publicado: (2023)

Long-Term Outcomes Following Myocardial Infarction in Young Adult Survivors of Hodgkin Lymphoma: The YOUNG-MI Registry
por: Divakaran, Sanjay, et al.
Publicado: (2021)

Hodgkin's lymphoma presenting as chylothorax
por: Verma, Sanjeev Kumar, et al.
Publicado: (2014)

Advances in Hodgkin Lymphoma: Including the Patient’s Voice
por: Smith, Christine Moore, et al.
Publicado: (2022)

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma
por: Mangano, Chiara, et al.
Publicado: (2019)

Prolonged and recurrent hypoglycemia induced by trimethoprim-sulfamethoxazole in a Hodgkin lymphoma patient with Pneumocystis carinii pneumonia
por: Wang, Bing-Jie, et al.
Publicado: (2021)

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
por: Alkhateeb, Hassan B., et al.
Publicado: (2022)

Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas.
por: Hawkins, M. M., et al.
Publicado: (1995)

Therapy-Related Myeloid Neoplasm in Non-Hodgkin Lymphoma Survivors
por: Bari, Alessia, et al.
Publicado: (2011)

Cancer-Related Fatigue and Muscle Quality in Hodgkin’s Lymphoma Survivors
por: de Lima, Filipe Dinato, et al.
Publicado: (2017)

Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
por: Abuelgasim, Khadega A., et al.
Publicado: (2019)

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
por: Duraković, Nadira, et al.
Publicado: (2021)

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2022)

HIV-1 DNA levels in peripheral blood mononuclear cells of patients with HIV-related non-Hodgkin's lymphoma
por: Wang, Zhenyan, et al.
Publicado: (2023)

Hodgkin's lymphoma masquerading as suppurative lymphadenitis
por: Singh, Meghna, et al.
Publicado: (2017)

Non-Hodgkin lymphoma mimicking cholangiocarcinoma
por: Mendes, Gustavo Gomes, et al.
Publicado: (2019)

Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients
por: Bari, Alessia, et al.
Publicado: (2016)

Bone marrow involvement by classic Hodgkin lymphoma
por: Barouqa, Mohammad, et al.
Publicado: (2022)

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
por: Richter, Julia, et al.
Publicado: (2019)

Erratum: Correction of Affiliations in the Article “Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study”
por: Lee, Jae Min, et al.
Publicado: (2021)

High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors?
por: Andersson, Anne, et al.
Publicado: (2021)

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity
por: Daniëls, L A, et al.
Publicado: (2014)

Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History
por: Sud, Amit, et al.
Publicado: (2017)

Proposal of ‘reactive‐lymphocyte/histiocyte rich large B‐cell lymphoma’ as an alternate term for ‘nodular lymphocyte predominant Hodgkin lymphoma’ that would also address its overlap with T‐cell/histiocyte rich large B‐cell lymphoma
por: Naresh, Kikkeri N.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2po3eb28njp6le9k6urol1m0or